{"id":"W4400319636","doi":"10.1080/13696998.2024.2367919","title":"The real-world observational prospective study of health outcomes with dulaglutide and liraglutide in type 2 diabetes patients (TROPHIES): resource use and costs of treatment in clinical practice in France, Germany, and Italy","year":2024,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Eli Lilly (Canada)","funders":"Insulet Corporation; Gilead Sciences; Novo Nordisk; Sanofi; AstraZeneca; Eli Lilly and Company; Roche Diabetes Care; Amgen","keywords":"Medicine; Observational study; Liraglutide; Type 2 diabetes; Dulaglutide; Exenatide; Health care; Diabetes mellitus; Glucagon-like peptide 1 receptor; Real world evidence; Intensive care medicine; Internal medicine; Family medicine; Agonist; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00163461,0.0001097331,0.0005970894,0.00021899,0.00001872407,0.00002383907,0.00004950341,0.00004201215,0.000001426335],"category_scores_gemma":[0.0005660037,0.0000647902,0.0000279046,0.0001588657,0.0001410994,0.0001962626,0.00005308658,0.000202514,8.978106e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002503697,"about_ca_system_score_gemma":0.0002372774,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003583608,"about_ca_topic_score_gemma":0.002264042,"domain_scores_codex":[0.9983307,0.000147412,0.001016539,0.0001600154,0.000207568,0.0001378056],"domain_scores_gemma":[0.9975986,0.00174977,0.0003887884,0.00009611801,0.00005985684,0.0001068899],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000345298,0.00116868,0.9725254,0.00004697853,0.0003583406,0.0000375887,0.000731475,0.00001768601,1.31269e-7,0.0003795304,0.00003975349,0.02434913],"study_design_scores_gemma":[0.006293241,0.004492833,0.9861577,0.0004891696,0.0001041576,0.000002508034,0.0007310949,0.0005035484,7.416999e-7,0.00006898025,0.001109893,0.00004617688],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938399,0.001650639,3.049101e-7,0.003788092,0.00007315262,0.0005838022,0.000003377182,0.000001949012,0.00005877806],"genre_scores_gemma":[0.991926,0.007559306,0.0001875637,0.0002388726,0.0000239144,0.000008517366,0.000002407046,0.000009557333,0.00004392923],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02430295,"threshold_uncertainty_score":0.2642068,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03135285047652705,"score_gpt":0.3399828926197037,"score_spread":0.3086300421431767,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}